Norges Bank purchased a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 9,549,137 shares of the real estate investment trust’s stock, valued at approximately $153,550,000.
Several other hedge funds also recently made changes to their positions in the business. State Street Corp grew its stake in shares of Healthpeak Properties by 1.8% during the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after acquiring an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Healthpeak Properties by 41.0% in the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after buying an additional 8,212,504 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Healthpeak Properties by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock valued at $312,959,000 after buying an additional 123,274 shares in the last quarter. Cullen Capital Management LLC increased its holdings in Healthpeak Properties by 6.7% during the third quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock worth $195,960,000 after buying an additional 641,771 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in Healthpeak Properties by 4.1% during the third quarter. Dimensional Fund Advisors LP now owns 10,228,560 shares of the real estate investment trust’s stock worth $195,873,000 after buying an additional 400,900 shares during the last quarter. 93.57% of the stock is owned by institutional investors.
Healthpeak Properties Trading Down 1.6%
DOC stock opened at $19.14 on Thursday. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. The company has a fifty day moving average price of $17.84 and a two-hundred day moving average price of $17.36. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $20.27. The stock has a market cap of $13.19 billion, a price-to-earnings ratio of 59.80, a price-to-earnings-growth ratio of 3.04 and a beta of 1.05.
Healthpeak Properties Dividend Announcement
The business also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be given a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 6.4%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties’s payout ratio is 381.25%.
Insider Buying and Selling
In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.23% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
A number of analysts have commented on DOC shares. Robert W. Baird increased their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Wells Fargo & Company increased their price target on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a research note on Monday. Scotiabank increased their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 27th. Royal Bank Of Canada increased their price target on shares of Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Thursday, May 14th. Finally, Citigroup increased their price target on shares of Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Four equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat, Healthpeak Properties presently has an average rating of “Hold” and a consensus target price of $19.38.
Check Out Our Latest Research Report on Healthpeak Properties
About Healthpeak Properties
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
